Here's Why Moderna Stock Soared 16% on Wednesday

Shares of Moderna (MRNA) rose nearly 16% yesterday after a couple of SEC filings showed that two board members bought shares on the open market. It also secured a legal victory in a patent dispute against Pfizer (PFE) and BioNTech (BNTX) .MRNA Insiders Buy Shares Worth $6MIn a couple of regulatory filings with the SEC, it was revealed that Moderna’s CEO Stephane Bancel and director Paul Sagan acquired common stock worth$6 million.On Monday, Bancel acquired 160,314 shares worth $5 million through a firm, na ...